[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Viridian Therapeutics Inc (VRDN)

Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,612,513
  • Shares Outstanding, K 113,292
  • Annual Sales, $ 70,850 K
  • Annual Income, $ -342,600 K
  • EBIT $ -405 M
  • EBITDA $ -412 M
  • 60-Month Beta 0.91
  • Price/Sales 37.72
  • Price/Cash Flow N/A
  • Price/Book 4.82

Options Overview Details

View History
  • Implied Volatility 95.95% (-3.50%)
  • Historical Volatility 52.47%
  • IV Percentile 59%
  • IV Rank 26.97%
  • IV High 214.65% on 03/20/26
  • IV Low 52.12% on 05/20/26
  • Expected Move (DTE 10) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.37
  • Today's Volume 86
  • Volume Avg (30-Day) 213
  • Put/Call OI Ratio 2.24
  • Today's Open Interest 9,388
  • Open Int (30-Day) 11,514
  • Expected Range 22.97 to 22.97

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-1.02
  • Number of Estimates 5
  • High Estimate $-0.93
  • Low Estimate $-1.13
  • Prior Year $-0.34
  • Growth Rate Est. (year over year) -200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.54 +30.96%
on 07/17/26
23.83 -3.61%
on 08/11/26
+3.23 (+16.36%)
since 07/10/26
3-Month
15.50 +48.19%
on 06/10/26
23.83 -3.61%
on 08/11/26
+5.77 (+33.55%)
since 05/11/26
52-Week
13.18 +74.28%
on 04/29/26
34.29 -33.01%
on 01/14/26
+6.08 (+36.00%)
since 08/11/25

Most Recent Stories

More News
Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

- Lumvoa™ (veligrotug-vvze) approved by the FDA for thyroid eye disease (TED) on June 26, 2026, ahead of target PDUFA date and immediately launched in the U.S. - - Elegrobart,...

VRDN : 22.97 (-0.39%)
Viridian's First Commercial Launch May Expose How Quickly Rare Disease Markets Actually Saturate

Barchart Research What to Expect from VRDN Earnings VRDN Generated August 4, 2026 Current Price $20.84 EPS Estimate $$-0.97 Consensus Rating Strong Buy Average Move 8.67% Viridian's First Commercial Launch...

VRDN : 22.97 (-0.39%)
Stock Indexes Finish Sharply Higher as Tech Soars

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +1.18%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.59%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.25%. September E-mini...

GOOGL : 343.80 (-3.84%)
AVGO : 416.08 (-1.50%)
VZ : 47.27 (+0.51%)
AXON : 636.31 (+6.70%)
$IUXX : 29,525.48 (-0.33%)
ASML : 1,799.38 (+3.80%)
MLM : 553.67 (+0.75%)
ZNU26 : 108-150 (-0.01%)
IRDM : 49.38 (+0.12%)
ESU26 : 7,754.50 (+0.09%)
T : 24.50 (+1.87%)
STX : 820.52 (+2.44%)
Stock Indexes Push Higher as Megacap Tech Stocks Rally

The S&P 500 Index ($SPX ) (SPY ) is up +0.73% today; the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.08%. September E-mini S&P futures...

GOOGL : 343.80 (-3.84%)
AAPL : 304.91 (-1.09%)
SNDK : 1,271.05 (+2.68%)
MLM : 553.67 (+0.75%)
TSLA : 332.81 (+0.58%)
AMD : 474.32 (+1.01%)
RBLX : 36.22 (-2.24%)
DOCS : 26.11 (+1.87%)
SPY : 770.56 (-0.32%)
META : 599.12 (+0.71%)
ADSK : 251.59 (-1.75%)
MU : 868.52 (+0.87%)
Stock Indexes Supported by Strength in Megacap Tech Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.59%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.67%. September E-mini S&P futures...

GOOGL : 343.80 (-3.84%)
AAPL : 304.91 (-1.09%)
INTU : 336.44 (+0.60%)
SNDK : 1,271.05 (+2.68%)
DDOG : 246.78 (-5.37%)
AXON : 636.31 (+6.70%)
TXN : 281.24 (+0.29%)
$IUXX : 29,525.48 (-0.33%)
MLM : 553.67 (+0.75%)
ZNU26 : 108-150 (-0.01%)
MSFT : 503.81 (-0.44%)
IRDM : 49.38 (+0.12%)
Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease

- First approved treatment for thyroid eye disease (TED) with labeling that includes data for both active and chronic TED - - In two pivotal phase 3 clinical trials, Lumvoa...

VRDN : 22.97 (-0.39%)
Viridian Therapeutics to Participate in Upcoming June Investor Conferences

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today announced...

VRDN : 22.97 (-0.39%)
Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for autoimmune and rare diseases, today announced...

VRDN : 22.97 (-0.39%)
Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for autoimmune and rare diseases, today announced...

VRDN : 22.97 (-0.39%)
Viridian Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Progress

- PDUFA target action date of June 30, 2026 for veligrotug in thyroid eye disease (TED); organization is launch-ready - - Marketing Authorization Application (MAA) for...

VRDN : 22.97 (-0.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Viridian Therapeutics Inc. is a biotechnology company advancing new treatments for patients suffering from serious diseases. The company's program includes VRDN-001, which is in clinical stage. Viridian Therapeutics Inc., formerly known as miRagen Therapeutics Inc., is based in BOULDER, Colo.

See More

Key Turning Points

3rd Resistance Point 24.62
2nd Resistance Point 24.22
1st Resistance Point 23.60
Last Price 22.97
1st Support Level 22.58
2nd Support Level 22.18
3rd Support Level 21.56

See More

52-Week High 34.29
Fibonacci 61.8% 26.23
Fibonacci 50% 23.74
Last Price 22.97
Fibonacci 38.2% 21.24
52-Week Low 13.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.